FDA recalls HeartStart MRx defibrillators

Philips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail. The Food and Drug Administration (FDA) issued a notice which outlines the details.

If the recalled defibrillator is used in automated external defibrillator mode after failing, the device will not deliver patient therapy, which may lead to serious injury or death.